Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Sarcoma Soft Tissue Clinical Trials
Sarcoma Soft Tissue clinical trials are recruiting across 58 cities. Here are the cities with the most active studies:
Sarcoma Soft Tissue Trial Phases
40 research organizations are sponsoring sarcoma soft tissue trials.
About Sarcoma Soft Tissue
Soft tissue sarcomas are rare cancers that develop in the soft tissues of the body including muscle, fat, blood vessels, and tendons. There are more than 50 subtypes, each with different characteristics. Treatment includes surgery, radiation, and chemotherapy, with newer targeted therapies under investigation.
Clinical trials are advancing new treatments for sarcoma soft tissue. Currently, 51 studies are recruiting a combined 7,476 participants across the United States. Research is being conducted by 40 organizations including Children's Hospital of Philadelphia, Eli Lilly and Company, VA Office of Research and Development and 37 others.
2026 Sarcoma Soft Tissue Research Landscape
As of July 2026, the sarcoma soft tissue clinical trial landscape includes 51 actively recruiting studies across 58 cities in the United States. These studies are collectively seeking 7,476 participants, with an average enrollment target of 147 per study.
The research spans multiple phases of development: 20 studies are in PHASE2, 14 studies are in PHASE1, 10 studies are in NA, 3 studies are in EARLY_PHASE1, 2 studies are in PHASE4, 2 studies are in PHASE3. The presence of Phase 3 trials indicates that some sarcoma soft tissue treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 40 different organizations, including Children's Hospital of Philadelphia, Eli Lilly and Company, VA Office of Research and Development, Abbott Point of Care, Rutgers, The State University of New Jersey, and 35 others. The large number of sponsors reflects significant research interest and investment in sarcoma soft tissue treatment advancement.
Geographically, sarcoma soft tissue trials are most concentrated in Houston, Texas (12 trials); New York, New York (9 trials); Chicago, Illinois (7 trials); Ann Arbor, Michigan (6 trials); Atlanta, Georgia (5 trials) and 7 other cities.
Featured Sarcoma Soft Tissue Studies
Highlighted recruiting studies for sarcoma soft tissue, selected by enrollment size and research scope.
Synovial Sarcoma Registry / Biospecimen Repository
The purpose of this study is to collect and store data and samples for future research to attempt to improve outcomes for patients with synovial sarcoma. The future research will involve various types of genetic testing. Participants will be asked to allow access to medical records and leftover tumor tissue and may be asked to give a blood or saliva sample. Participants will also be asked to comp...
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib. The clinical studies that will feed into this master protocol are referred to as originator studies. The master protocol will govern individual study-specific appendices (ISAs) that will represent pa...
Advancing Decisions About Virtual Service Encounters
Expanded availability of virtual care encounters in Primary Care provides new opportunities to improve Veterans' outcomes by aligning encounter modalities with their needs and preferences. Yet, Veterans and their Primary Care physicians (PCPs) lack personalized information about the benefits and costs of different Primary Care modalities that is needed to maximize the value of Primary Care encount...
Frequently Asked Questions About Sarcoma Soft Tissue Clinical Trials
Are there sarcoma soft tissue clinical trials near me?
Yes, there are 51 sarcoma soft tissue clinical trials currently recruiting across 58+ cities in the United States, including Houston, Texas; New York, New York; Chicago, Illinois. Browse the studies above to find one at a location convenient for you.
How do I join a sarcoma soft tissue clinical trial?
To join a sarcoma soft tissue clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are sarcoma soft tissue clinical trials free?
Yes, participation in sarcoma soft tissue clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of sarcoma soft tissue treatments are being studied?
Current sarcoma soft tissue clinical trials are testing a range of approaches across PHASE2 (20 studies), PHASE1 (14 studies), NA (10 studies), EARLY_PHASE1 (3 studies), PHASE4 (2 studies), PHASE3 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 40 research organizations.
Is it safe to participate in sarcoma soft tissue clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 14, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 14, 2026 · Data from ClinicalTrials.gov